Tigard firm signs deal with Bausch + Lomb

| Print |  Email
Must Reads
Monday, April 22, 2013

A small Tigard firm signed a deal with Bausch + Lomb for an eye-dilation product.

The product, called phenylephrine hydrochloride ophthalmic solution, was already in use by opthamologists and sold by Bausch + Lomb. However, it existed in a legal gray area of products that had never gone through the formal federal drug approval process.

Patrick Witham, President and CEO of Paragon BioTeck, Inc., submitted a drug approval request for the product in late 2012. Last month, the Food and Drug Administration approved Paragon's application, giving his firm sole right to market the drug.

Read more at OregonLive.com.

{biztweet}tigard bausch + lomb{/biztweet}

 

More Articles

5 companies react to lower fuel prices

The Latest
Thursday, January 15, 2015
thumb-shutterstock 233787049BY JACOB PALMER | OB DIGITAL NEWS EDITOR

Consumers love the savings they get from low oil prices, but how has business been affected?


Read more...

LEED for weed

Linda Baker
Wednesday, January 28, 2015
012815-potcarbon-thumbBY LINDA BAKER | OB EDITOR

What is the impact of the legal pot industry on carbon emissions?


Read more...

Money Talks

March 2015
Saturday, February 21, 2015
BY LINDA BAKER | OB EDITOR

Will community banks survive the digital age? Three CEOs peer into banking's crystal ball.


Read more...

Photos from the 100 Best Companies to Work For in Oregon awards celebration

The Latest
Friday, February 27, 2015
IMG 9975cneditPHOTOS BY JASON E. KAPLAN

Images from the 2015 celebration of Oregon's great workplaces.


Read more...

The city as startup

Guest Blog
Wednesday, January 14, 2015
011415 citystartup-thumbBY NISHANT BHAJARIA | OP-ED CONTRIBUTOR

Startups in the growth phase are associated with a fresh infusion of capital — human and financial — a curiosity factor and products to disrupt the market and drive demand. Portland’s economy gives off the same aroma.


Read more...

Nuclear fingerprints

March 2015
Tuesday, February 24, 2015
BY LINDA BAKER | OB EDITOR

At Oregon State University, a 21st century version of the bad dream — nuclear terrorism — is alive and well. This winter, the Department of Nuclear Physics and Radiation Health Physics created a new interdisciplinary graduate emphasis in nuclear forensics, a Sherlock Holmes-sounding program that aims to identify how and where confiscated nuclear and radiological materials were created.


Read more...

Cache and Curry

March 2015
Monday, February 23, 2015
BY JACOB PALMER | OB DIGITAL NEWS EDITOR

Power Lunch at Swagat in Hillsboro.


Read more...
Oregon Business magazinetitle-sponsored-links-02
SPONSORED LINKS